OrbitalsGeisinger ClinicSpectrumNude Mice - XenograftsDNA Helix
Home
Research Interests
Publications
Teaching
Ahmed Lab
Collaborators
Visiting Scholars
Funding Sources
Former Lab Members
Protocols
Databases
Lab in News
Lab Picture Gallery
Journal Club
Job Openings
      Other  Links
Weis Center
Geisinger Clinic





 


                                                                                  Funding Sources
Active

Principal Investigator Co-Investigator

Mansoor M Ahmed


TGF-b1 signaling and radiation response in pancreas cancer. RO-1 grant from National Cancer Institute, NIH ? Direct and Indirect $ 698,008 (April 2002 ? March 2005). 

Mansoor M Ahmed

 

TGF-b signaling and radiation response in lung carcinoma.  Kentucky Lung Cancer Research Board.  Direct and Indirect $250,000 (October 2001 to September 2004).
Susanne M. Arnold,

Mansoor M Ahmed

Low-dose fractionated radiation plus Docetaxel and Cisplatin as induction therapy for stage II and IIIA non-small cell lung cancer. Kentucky Lung Cancer Research Board.  Direct and Indirect $200,000 (March 2003 to Febraury 2005). 
Damodaran Chendil

Mansoor M Ahmed

Inhibition of radiation-induced pro-survival proteins by Curcumin, a natural dietary compound. Career Award funded by US Army Medical Research and Materiel Command-PCRP - Direct: $81,500/year (April 2003 to March 2005).
Paul M. Spring,

Mansoor M Ahmed

Multi-drug resistance and low-dose fractionated radiation. Aventis Pharmaceuticals, NJ. Direct and Indirect $40,353 (September 2001 to August 2002). 
Mariana Saltanov Mansoor M Ahmed (Mentor) EGR-1 functional activation, signaling and radiation response in prostate cancer. US Army Medical Research and Materiel Command-PCRP / Post-doctoral Award. Direct and Indirect $ 97,672 for 2 year. 
Seema Gupta Mansoor M Ahmed (Mentor) Radiosensitizing effects of novel HDAC inhibitors in prostate cancer. US Army Medical Research and Materiel Command-PCRP / Post-doctoral Award. Direct and Indirect $ 98,000 for 2 year
Pending



Mansoor M Ahmed


Biology of spatially fractionated radiation.  RO-1 grant application.  National Cancer Institute, NIH ? Direct $1,250,000.   (First round Percentile 47% and score 264).
Mansoor M Ahmed


Hyper-radiation sensitivity and chemo-potentiation in treatment of solid tumors. RO-1 grant application.  National Cancer Institute, NIH ? Direct $1,250,000. 
Paul M. Spring, Mansoor M Ahmed Novel strategy to reverse chemo-resistance in anaplastic cancer. VA-Research Career Development Award. 




Awarded


Mansoor M Ahmed
EGR-1 and apoptosis in prostate cancer.  RO-1 grant from National Cancer Institute, NIH ? Direct and Indirect $742,837 (July 1999 ? December 2003). 
Mansoor M Ahmed
Defining the genetic basis of chemosensitization of Taxotere with low dose fractionated radiation. Aventis Pharmaceuticals, NJ. Direct and Indirect $40,353
Mansoor M Ahmed
Role of Early Growth Response-1 (Egr-1) gene in radiation-induced apoptosis of prostate cancer cells.  Career Award funded by US Army Medical Research and Materiel Command - Direct: $63,902/year (July 1998 to April 2001).
Mansoor M Ahmed
Evaluation of Egr-1 overexpression and mutation in prostate adenocarcinomas.  Funded by Translation Research Program of Radiation Therapy Oncology Group (RTOG) - $5,000/year (July 1998 to June 2001).
Mansoor M Ahmed
Evaluation of overexpression of growth-inhibitory and cell death regulatory genes in pancreatic adenocarcinomas : A correlative study using specimens from RTOG protocol number 97-04.  Funded by Markey Cancer Center Trust Fund - $7,500/year (March 1999 to Feb 2000).
Mansoor M Ahmed
EGR-1 and apoptosis in prostate cancer.  Bridge funding by Charlotte Geyer Foundation, New York - $99,998 (July 1998 to June 1999). 
Mohammed Mohiuddin,
Mansoor M Ahmed A phase I dose-escalation trial of combined therapy with L-778,123 and radiotherapy in patients with cancer  Funded by Merck & Co - $13600/patient (March 1999 to Febraury 2000). 
Nader N Hanna Mansoor M Ahmed Radiogene therapy in solid tumors.  Funded by American Cancer Society Institutional Research Grant (Markey Cancer Center) - $15,000/year (July 1998 ? June 1999). 
James W. Freeman,
 Mansoor M Ahmed
TGF-b alterations in pancreatic cancer. Supported University of Kentucky Research Foundation (Equipment grant - 1996 $15,000).
Joseph Valentino Mansoor M Ahmed Genotype and phenotype analysis in head and neck tumors using fluorescent in-situ hybridization Supported by University of Kentucky Medical Research Foundation (Equipment grant -1994  $29,000). 
Mohammed Mohiuddin Mansoor M Ahmed Detection of circulating minimal malignant clone Supported by University of Kentucky Medical Research Foundation ($15,000): 1994-95.

                                                                                           
         


 

 

 

 

 

     

 



This site is designed and maintained by
 Mohammed Momin Shareef and Shahid Mohammed Saleem
Last updated on 11/27/2005